TOPIC

/ company

Macquarie

The latest news and top stories on Macquarie. A leading entity in the financial services sector, Sydney Australia based Macquarie is a global investment banking and financial services group. They specialise in asset management, retail and business banking, wealth management, and advisory services, serving government institutional corporate and retail clients worldwide. Known as one of the world’s largest infrastructure asset managers and a global specialist in renewables and commodities, Macquarie’s overall business focus is on providing diversified financial solutions. Larry Hu serves as its chief China economist.

There were more than 400 million overweight or obese adults in China in 2021, according to a study. Photo: Getty Images

Made in China 2025

China’s weight-loss drug war: prices slashed up to 80% as obesity crisis worsens

Foreign, local firms fight for market share as number of overweight or obese adults could top 630 million by 2050, from 400 million in 2021.

13 Jan 2026 - 7:30AM

Chinese culture

Language Matters | Word of the Year 2025 choices reflect how virtual our reality has become

20 Dec 2025 - 5:15PM

United States

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

20 Dec 2025 - 8:57AM

Made in China 2025

China’s new drug insurance: lifeline for patients or squeeze on big firms?

New insurance formulary trims costs of Alzheimer’s and cancer therapies and marks a small win for global novel drug makers.

17 Dec 2025 - 7:30AM

The commercial insurance formulary covers some medicines that are not yet eligible for reimbursement under the country’s National Reimbursement Drug List. Photo: Shutterstock

Hong Kong Monetary Authority (HKMA)

Exclusive | From boardrooms to hiking trails: HKMA courts top bankers with business and leisure

BlackRock’s Larry Fink and General Atlantic’s William Ford will attend the HKMA summit for the first-time.

27 Oct 2025 - 6:27PM

US-China trade war

US-China trade flare-up a short-term scare as both sides seek off-ramp: analysts

While US President Donald Trump’s threat of 100 per cent tariffs triggered alarm bells, experts said neither side wants to derail talks.

13 Oct 2025 - 11:25PMvideocam

Biomedicine: Industry Trends

China’s drug developers stretch to become a global force

Although a start-up’s recent triumph is seen as a ‘DeepSeek moment’, domestic players still trail world-beating pharma firms, experts say.

4 Oct 2025 - 10:56AM

IPO

Chinese healthcare, biotech firms flock to Hong Kong for IPOs

September yields at least 23 listing applications from mainland biotech firms eyeing the city’s lucrative fundraising market.

2 Oct 2025 - 4:30PM

Biomedicine: Companies

Pfizer’s Metsera acquisition to spur Chinese search for new weight drugs

The deal, worth up to US$7.3 billion, will encourage ongoing investment by mainland players but not draw in new rivals, analysts say.

26 Sep 2025 - 12:15PM

Banking & finance

After Fed cut, moderate easing expected by China’s central bank, supporting yuan

PBOC sets yuan’s midpoint rate at 7.1085 after first US interest rate cut since December.

18 Sep 2025 - 5:53PMvideocam

Banknotes from the United States and China. Photo: DPA

India

‘Not desperate’: why India remains firm on US tariff talks as it seeks a deal

The US continues to pressure India to open its agricultural sector after it imposed a 50 per cent tariff on Indian goods.

11 Sep 2025 - 5:00PMvideocam

US President Donald Trump meets Indian Prime Minister Narendra Modi in the White House in Washington in February. The US and India are holding trade talks after Washington recently imposed a 50 per cent tariff on Indian imports. Photo: AFP

Australia

Opinion | The online radicalisation of Australia is here and Elon Musk is a part of it

Backed by global far-right figures, the ‘March for Australia’ highlighted transnational links and social media’s role in spreading extremism.

8 Sep 2025 - 9:59AMvideocam